Status Epilepticus
📧 Sign up to get email alerts when something new happens for Status Epilepticus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-01-28FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for CEREBYX (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2019-02-21FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Diazepam filed by Hospira, Inc. (ANDA 072079).
-
FDA approval · 2019-02-21FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for diazepam from Hospira, Inc., indicating updated labeling and continued availability under th…
-
FDA approval · 2018-03-08FDA Approved: FOSPHENYTOIN SODIUM — Supplemental Application (West-Ward Pharmaceuticals Corp)
FDA approved a supplemental application for fosphenytoin sodium submitted by West-Ward Pharmaceuticals Corp. The action updates labeling for…
-
FDA approval · 2017-12-22FDA Approved: LORAZEPAM — Original Application (Aurolife Pharma LLC)
FDA approved Aurolife's original application for lorazepam, a generic benzodiazepine.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-10-31FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2017-03-10FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) from Pfizer Laboratories Div Pfizer Inc. The approval updates …
-
FDA approval · 2017-03-01FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2016-06-16FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc, expanding the…
-
FDA approval · 2016-05-16FDA Approved: FOSPHENYTOIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for fosphenytoin sodium from Fresenius Kabi USA, LLC under an existing ANDA.
-
FDA approval · 2016-05-02FDA Approved: DIAZEPAM INTENSOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Diazepam Intensol from Hikma Pharmaceuticals USA Inc., confirming changes to the approved pr…
-
FDA approval · 2016-04-18FDA Approved: LORAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lorazepam from Hikma Pharmaceuticals USA Inc., indicating an approved update to the drug's l…
-
FDA approval · 2016-03-03FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2015-03-09FDA Approved: DIAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a Teva supplemental application for Diazepam, resulting in an approved labeling change under ANDA 071321.
-
FDA approval · 2014-07-03FDA Approved: DILANTIN — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Dilantin (extended phenytoin sodium) by Viatris Specialty LLC. The approval concerns the extende…
-
FDA approval · 2014-06-12FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2014-06-09FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2014-05-13FDA Approved: LORAZEPAM — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for lorazepam by Hospira, Inc.
-
FDA approval · 2014-01-03FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2013-09-25FDA Approved: FOSPHENYTOIN SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for fosphenytoin sodium by Hikma Pharmaceuticals USA Inc., approving changes to the approved product…
-
FDA approval · 2013-01-28FDA Approved: DIAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for diazepam from Teva Pharmaceuticals USA, Inc. The action represents an additional approval or mod…
-
FDA approval · 2012-09-13FDA Approved: LORAZEPAM — Supplemental Application (International Medication Systems, Limited)
FDA approved a supplemental application for lorazepam from International Medication Systems, Limited.
-
FDA approval · 2010-06-15FDA Approved: LORAZEPAM — Original Application (Pharmaceutical Associates, Inc.)
FDA approved Lorazepam under an Original Application for an ANDA held by Pharmaceutical Associates, Inc., establishing a generic version of …
-
FDA approval · 2009-12-23FDA Approved: LORAZEPAM — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal Pharmaceuticals' generic lorazepam (oral) under an Original Application (ANDA 091383).
-
FDA approval · 2009-12-02FDA Approved: FOSPHENYTOIN SODIUM — Original Application (West-Ward Pharmaceuticals Corp)
FDA approved the original application for fosphenytoin sodium (generic) from West-Ward Pharmaceuticals Corp, authorizing its use as an antic…